Almado, Inc. Share Price

Equities

4932

JP3126480007

Personal Products

Market Closed - Japan Exchange 07:00:00 26/04/2024 BST 5-day change 1st Jan Change
1,443 JPY +0.63% Intraday chart for Almado, Inc. +3.44% +3.81%

Financials

Sales 2024 * 7.7B 48.61M 3.89B Sales 2025 * 9B 56.82M 4.55B Capitalization 13.34B 84.21M 6.74B
Net income 2024 * 765M 4.83M 387M Net income 2025 * 840M 5.3M 425M EV / Sales 2024 * 1.64 x
Net cash position 2024 * 718M 4.53M 363M Net cash position 2025 * 662M 4.18M 335M EV / Sales 2025 * 1.41 x
P/E ratio 2024 *
17.7 x
P/E ratio 2025 *
16.1 x
Employees 41
Yield 2024 *
4.5%
Yield 2025 *
4.85%
Free-Float 51.85%
More Fundamentals * Assessed data
Dynamic Chart
Tranche Update on Almado, Inc.'s Equity Buyback Plan announced on February 14, 2024. CI
Almado, Inc.'s Equity Buyback announced on February 14, 2024, has closed with 146,500 shares, representing 1.53% for ¥245.55 million. CI
Almado, Inc. announces an Equity Buyback for 250,000 shares, representing 2.66% for ¥300 million. CI
Almado, Inc. authorizes a Buyback Plan. CI
Tranche Update on Almado, Inc.'s Equity Buyback Plan announced on November 14, 2023. CI
Almado, Inc.'s Equity Buyback announced on November 14, 2023, has closed with 222,300 shares, representing 2.31% for ¥300 million. CI
Almado, Inc. announces an Equity Buyback for 300,000 shares, representing 3.12% for ¥300 million. CI
Almado, Inc. authorizes a Buyback Plan. CI
Tranche Update on Almado, Inc.'s Equity Buyback Plan announced on November 21, 2022. CI
Almado, Inc.'s Equity Buyback announced on November 21, 2022 has closed with 127,500 shares, representing 1.31% for ¥149.95 million. CI
Almado, Inc. announces an Equity Buyback for 150,000 shares, representing 1.55% for ¥150 million. CI
Almado, Inc. authorizes a Buyback Plan. CI
Tranche Update on Almado, Inc.'s Equity Buyback Plan announced on August 12, 2022. CI
Almado, Inc.'s Equity Buyback announced on August 12, 2022 has closed with the repurchase of 98,200 shares, representing 0.99% for ¥131.28 million. CI
CBC Co., Ltd. agreed to acquire additional 10.26% stake in Almado, Inc. from Ant Bridge No.4-A Private Equity Secondary Investment Fund, Limited Partnership, managed by Ant Capital Partners Co., Ltd.. CI
More news
1 day+0.63%
1 week+3.44%
Current month-8.21%
1 month-10.98%
3 months-0.14%
6 months+15.16%
Current year+3.81%
More quotes
1 week
1 394.00
Extreme 1394
1 448.00
1 month
1 387.00
Extreme 1387
1 596.00
Current year
1 387.00
Extreme 1387
1 717.00
1 year
1 110.00
Extreme 1110
1 717.00
3 years
419.00
Extreme 419
1 784.00
5 years
419.00
Extreme 419
1 784.00
10 years
419.00
Extreme 419
1 784.00
More quotes
Managers TitleAgeSince
President 62 30/11/14
Chief Administrative Officer 41 31/07/18
Director/Board Member 63 30/04/06
Members of the board TitleAgeSince
President 62 30/11/14
Director/Board Member 63 30/04/06
Chief Administrative Officer 41 31/07/18
More insiders
Date Price Change Volume
26/04/24 1,443 +0.63% 20,700
25/04/24 1,434 +0.70% 13,700
24/04/24 1,424 +1.35% 12,800
23/04/24 1,405 +0.07% 33,900
22/04/24 1,404 +0.65% 15,900

Delayed Quote Japan Exchange, April 26, 2024 at 07:00 am

More quotes
Almado Inc manufactures and sells food and cosmetics using eggshell membrane materials. All food and cosmetics production are outsourced. The Company operates the Eggshell Membrane Healthcare business segment. Sales channels include television (TV) shopping sales, external indirect sales and in-house direct sales. In TV shopping sales, the Company introduces eggshell membrane foods and eggshell membrane cosmetics through QVC TV shopping, a TV shopping specialty channel. The main products are the Ode series of cosmetics and TO-II of food. External indirect sales include sales of original equipment manufacturing (OEM) products and wholesale sales. In-house direct sales receive orders directly from end consumers through their own e-commerce sites and other companies' e-commerce sites. Major products include the CELLULA series of cosmetics.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings